Histopathological and Radiological Correlation of Lung Mass Lesions with Transthoracic Biopsy and Endobronchial Biopsy

Abstract

The aim of this study is to correlate radiological CT imaging approaches to the lesion and pathology results in lung lesions. In this study, lung biopsy pathology results of 54 cases sent to the pathology department between 2020-2023 were compared with existing radiological CT images. The cases were grouped pathologically as benign and malignant, and the malignant cases were classified according to their tumor types. Radiologically, the cases were divided into groups as benign or malignant, peripheral or centrally located. In this study, core biopsies of a total of 54 cases, 15 female (27.7%) and 39 (72.3%) male, were evaluated. The average age of the patients was found to be 61.1 (21-95). Of a total of 54 lung solid mass lesions, 38 (70.4%) were peripheral and 16 (29.6%) were centrally located. In the radiological double-blind evaluation, 29 (53.7%) of the cases were diagnosed as malignant, while 24 (44.4%) were pathologically diagnosed as malignant. While squamous cell carcinoma (SCC), the most common pathologically malignant tumor, was seen in 9 cases, the second most common small cell carcinoma (SCLC) was detected in 7 cases. In conclusion, pathology and radiological imaging in lung lesions are important in early diagnosis, effective treatment and prolonged survival, and correctly performed radiological imaging and histopathological correlation with biopsy with today's interventional techniques in early suspicious cases have an important place in reducing morbidity and mortality.

Keywords

• Lung cancer
• Transthoracic biopsy
• Histopathology
• Malignant
• Benign

References

1. 1. Stabellini N, Bruno DS, Dmukauskas M, Barda AJ, Cao L, Shanahan J, et al. Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community Practice. JTO Clin Res Rep. 2022 Mar 9;3(4):100307. doi: 10.1016/j.jtocrr.2022.100307.
2. 2. Cruz. “Lung Cancer 2020: Epidemiology, Etiology, and Prevention.” Clinics in chest medicine 41 1 (2020): 1-24 . DOI: 10.1016/j.ccm.2019.10.001
3. 3. Worthy S. High resolution computed tomography of the lungs. BMJ. 1995 Mar 11;310(6980):615-6. doi: 10.1136/bmj.310.6980.616.
4. 4. Mathieson JR, Mayo JR, Staples CA, Müller NL. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology. 1989 Apr;171(1):111-116. DOI: 10.1148/radiology.171.1.2928513.
5. 5. Jaffé, J. L., et al. (2017). CT Imaging of Lung Neoplasms. Seminars in Roentgenology, 52(1), 19-28.
6. 6. Miller, R. H., & Turcios, N. L. (2017). Lung Cancer and its Radiological Evaluation. Clinical Chest Medicine, 38(2), 215–230.
7. 7. Hu B, Ren W, Feng Z, Li M, Li X, Han R, et al. Correlation between CT imaging characteristics and pathological diagnosis for subcentimeter pulmonary nodules. Thorac Cancer. 2022 Apr;13(7):1067-1075. doi: 10.1111/1759-7714.14363.
8. 8. Şahin C, Yılmaz O, Üçpınar BA, Uçak R, Temel U, Başak M, et al. Computed Tomography-guided Transthoracic Core Needle Biopsy of Lung Masses: Technique, Complications and Diagnostic Yield Rate. Sisli Etfal Hastan Tip Bul. 2020 Mar 25;54(1):47-51. doi: 10.14744/SEMB.2019.46338.

9. 9. Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol (Pozn). 2021;25(1):45-52. doi: 10.5114/wo.2021.103829.
10. 10. Wang S, Dong L, Wang X, Wang X. Classification of Pathological Types of Lung Cancer from CT Images by Deep Residual Neural Networks with Transfer Learning Strategy. Open Med (Wars). 2020 Mar 8;15:190-197. doi: 10.1515/med-2020-0028.
11. 11. Zheng, Min-Wen. “Classification and Pathology of Lung Cancer.” Surgical oncology clinics of North America 25 3 (2016): 447-68 .
12. 12. Cohen JG, Reymond E, Jankowski A, Brambilla E, Arbib F, Lantuejoul S, Ferretti GR. Lung adenocarcinomas: correlation of computed tomography and pathology findings. Diagn Interv Imaging. 2016 Oct;97(10):955-963. doi: 10.1016/j.diii.2016.06.021.